financetom
Business
financetom
/
Business
/
Update: China's Pony AI Expands Paid Robotaxi Services in Guangzhou; Shares Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: China's Pony AI Expands Paid Robotaxi Services in Guangzhou; Shares Rise
Feb 21, 2025 8:46 AM

11:22 AM EST, 02/21/2025 (MT Newswires) -- (Updates with the latest stock price movement in the headline and last paragraph.)

Pony AI (PONY) said Friday it introduced paid robotaxi services from multiple locations in Guangzhou's city center to Guangzhou Baiyun International Airport and Guangzhou South Railway Station in China.

The move comes after the autonomous mobility company introduced paid robotaxi rides to and from Beijing Daxing International Airport and to and from Beijing South Railway Station.

The company's US-listed shares were up more than 20% in recent trading.

Price: 21.96, Change: +4.08, Percent Change: +22.82

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Axel Springer CEO to stay on executive board after KKR deal
Axel Springer CEO to stay on executive board after KKR deal
Sep 25, 2024
BERLIN, Sept 19 (Reuters) - Axel Springer CEO Mathias Doepfner will sign a new five-year contract and remain chairman of a new executive board following the German media empire's deal with private equity firm KKR, he said in a message to employees on Thursday. Not only do we want to make it (the executive board) smaller, we want to organise...
Vanda Pharma Shares Fall 15% as FDA Denies Approval of Tradipitant NDA for Treating Gastroparesis Symptoms
Vanda Pharma Shares Fall 15% as FDA Denies Approval of Tradipitant NDA for Treating Gastroparesis Symptoms
Sep 25, 2024
08:26 AM EDT, 09/19/2024 (MT Newswires) -- Vanda Pharmaceuticals ( VNDA ) shares tumbled 15% premarket Thursday after the biopharmaceutical company said the US Food and Drug Administration declined to approve its new-drug application for tradipitant to treat symptoms in gastroparesis. Vanda said the FDA generally disregarded the evidence provided and instead suggested that Vanda conduct additional studies with a...
Edgewise Therapeutics Shares Up Pre-Bell After Results Show EDG-7500 is Well-Tolerated in 2 Trials
Edgewise Therapeutics Shares Up Pre-Bell After Results Show EDG-7500 is Well-Tolerated in 2 Trials
Sep 25, 2024
08:23 AM EDT, 09/19/2024 (MT Newswires) -- Edgewise Therapeutics ( EWTX ) shares went up 29% in Thursday's premarket activity after announcing that EDG-7500, an investigational treatment for cardiomyopathy, was found to be well-tolerated in two early trials. Results showed that EDG-7500 was well-tolerated in both a phase 1 study on healthy subjects and a phase 2 study on patients...
Solaris Reports On New Drilling In Ecuador
Solaris Reports On New Drilling In Ecuador
Sep 25, 2024
07:45 AM EDT, 09/19/2024 (MT Newswires) -- Solaris Resources Inc. ( SLSR ) reported Thursday assay results from its ongoing 60,000 metre 2024 drilling program that aims to target open extensions of mineralization while upgrading mineral resources and converting waste at its Warintza Project in southeastern Ecuador. Among highlights, Solaris in a statement said drill results continue to build on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved